Benitec Biopharma(BNTC) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth
Simply Wall StMar 3 07:39 ET
Piper Sandler Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $30
Moomoo NewsFeb 26 07:34 ET · Ratings
Benitec Biopharma to Participate in Upcoming Conferences in March
GlobeNewswireFeb 26 07:00 ET
Benitec Biopharma Analyst Ratings
BenzingaFeb 21 07:32 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Evolent Health (EVH), Benitec Biopharma (BNTC) and Ardelyx (ARDX)
TipRanksFeb 21 06:40 ET · Ratings
H.C. Wainwright Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $28
Moomoo NewsFeb 21 06:31 ET · Ratings

Comments

Teddy123

Feb 14 07:23

Clinical research analysis

$Benitec Biopharma (BNTC.US)$
The latest clinical and financial update from Benitec Biopharma presents a compelling narrative in the rare disease space. The BB-301 gene therapy program continues to demonstrate encouraging progress with five subjects now safely treated in the Phase 1b/2a trial for Oculopharyngeal Muscular Dystrophy (OPMD).
The interim data is particularly noteworthy as it shows durable improvements in both key measures of dysphagia: Total Pharyngeal Resi...

Teddy123

Feb 14 07:23

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update

$Benitec Biopharma (BNTC.US)$
Breakthrough in Muscular Dystrophy Treatment: Benitec's Clinical Trial Delivers Promising Results Amid Q2 Report

Teddy123

Feb 14 07:16

Clinical research analysis

$Benitec Biopharma (BNTC.US)$
The acceptance of a late-breaking oral presentation at the prestigious MDA conference carries significant weight in the clinical research community. Late-breaking abstracts are typically reserved for groundbreaking developments that emerge after standard submission deadlines, suggesting the data's novelty and potential importance.
The planned presentation of interim data from three subjects is particularly noteworthy in the context of rare ...

4

Teddy123

Feb 14 07:15

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference

$Benitec Biopharma (BNTC.US)$
Clinical Breakthrough: Benitec's Novel Muscular Dystrophy Therapy Demonstrates Remarkable Swallowing Improvements

Trytosaveabit

Dec 5, 2024 15:56

New form 4! Somebody a bit bullish. Hehehe!

$Benitec Biopharma (BNTC.US)$ One is from today! And im including the one from mid November just so you got a idea of how many they been buying! Hehehe

BNTC Benitec Biopharma

Trade Overview

Capital Trend

News

Comments

Trending Stocks